Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D3-induced differentiation of human leukemia HL60 cells

Experimental Cell Research

Volumn 258, Issue 2, 2000, Pages 425-437

  Wang, Xuening ^a   Rao, Jie ^a   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

ERK1 2 MAP kinase; JNK1 2 MAP kinase; p38 MAP kinase; Stress activated pathways; Vitamin D3

Indexed keywords

CALCITRIOL; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034255656     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4939     Document Type: Article

References (59)

1. Schlesinger T. K., Fanger G. R., Yujiri T., Johnson G. L. The TAO of MEKK. Front. Biosci. 3:1998;1181-1186.
2. Robinson M. J., Cobb M. H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:1997;180-186.
3. Rana A., Gallo K. A., Godowski P. J., Hirai S., Ohno S., Zon L., Kyriakis J. M., Avruch J. The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J. Biol. Chem. 271:1998;19025-19028.
4. Teramoto H., Coso O. A., Miyata H., Igishi T., Miki T., Gutkind J. S. Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress activated protein kinase pathway. J. Biol. Chem. 271:1996;27225-27228.
5. Tibbles L. A., Ing Y. L., Kiefer F., Chan J., Iscove N., Woodgett J. R., Lassam N. J. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J. 24:1996;7026-7035.
6. Hartkamp J., Troppmair J., Rapp U. R. The JNK/SAPK activator mixed linease kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion. Cancer Res. 59:1999;2195-2202.
7. Derijard B., Raingeaud J., Barrett T., Wu I. H., Han J., Ulevitch R. J., Davis R. J. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;682-685.
8. Enslen H., Raingeaud J., Davis R. J. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem. 273:1998;1741-1748.
9. Stein B., Brady H., Yang M. X., Young D. B., Barbosa M. S. Cloning an characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade. J. Biol. Chem. 271:1996;11427-11433.
10. Moriguchi T., Kuroyanagi N., Yamaguchi K., Gotoh Y., Irie K., Kano T., Shirakabe K., Muro Y., Shibuya H., Matsumoto K., Nishida E., Hagiwara M. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271:1996;13675-13679.
11. Raingeaud J., Whitmarsh A. J., Barrett T., Derijard B., Davis R. J. MKK3 and MKK6 regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell Biol. 16:1996;1247-1255.
12. Lin A., Minden A., Martnetto H., Claret F. X., Lange-Carter C., Mercurio P., Johnson G. L., Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p38 Mpk2. Science. 268:1995;286-290.
13. Whitmarsh A. J., Davis R. J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:1996;586-607.
14. Sturgill T. W., Ray L. B., Erikson E., Maller J. L. Insulin stimulated MAP-2 kinase phosphorylates and activates ribosomal-protein S6 kinase-II. Nature. 334:1988;715-718.
15. Treisman R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:1996;205-215.
16. Ip Y. T., Davis R. J. Signal transduction by the c-jun N-terminal kinase (JNK) from inflammation to development. Curr. Opin. Cell Biol. 2:1998;205-219.
17. Whitmarsh A. J., Yang S. H., Su M. S., Sharrocks A. D., Davis R. J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:1997;2360-2371.
18. Freshney N. W., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J., Saklatvala J. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell. 78:1994;1039-1049.
19. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A. R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP knase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037.
20. Gallagher R., Collins S., Trujillo J., McCredie K., Ahearn M., Tsai S., Metzgar R., Aulakh G., Ting R., Ruscetti F., Gallo R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 54:1979;713-733.
21. 3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem. Biophys. Res. Commun. 117:1983;86-92.
22. 3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk. Res. 7:1983;51-55.
23. 3 correlates with a reduced rate of maturation of DNA replication intermediates. Cancer Res. 51:1991;3451-3455.
24. Slack J. L., Gallagher R. E. The molecular biology of acute promyelocytic leukemia. Cancer Treat. Res. 99:1999;75-124.
25. Yen A., Roberson M. S., Varvayanis S., Lee A. T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58:1998;3163-3172.
26. Juan G., Traganos F., Darzynkiewicz Z. Histone H3 phosphorylation in human monocytes and during HL-60 cell differentiation. Exp. Cell. Res. 246:1999;212-220.
27. Beno D. W., Brady L. M., Bissonnette M., Davis B. H. Protein kinase C and mitogen activated protein kinase are required for 1,25-dihydroxyvitamin D3 stimulated Egr induction. J. Biol. Chem. 270:1995;3642-3647.
28. 3 in normal human keratinocytes. J. Invest. Dermatol. 106:1996;1212-1217.
29. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem. Biophys. Res. Commun.241, 419-426, 1997.
30. 3 in promyelocytic NB4 leukemia cells: A structure-function study. Endocrinology. 139:1998;457-465.
31. 3 signaling in chick enterocytes: Enhancement of tyrosine phosphorylation and rapid stimulation of mitogen-activated protein (MAP) kinase. J. Cell. Biochem. 69:1998;470-482.
32. 3-dependent signal transduction by phosphorylating human retinoid X receptor alpha. J. Clin. Invest. 103:1999;1729-1735.
33. 3 reverses the G1 block but not differentiation of HL60 cells. Leukemia. 12:1998;1256-1265.
34. 3. J. Natl. Cancer Inst. 89:1997;1199-1206.
35. 3-resistant HL60 cells is preceded by reduced growth factor dependence and constitutive up-regulation of Sp1 and AP-1 transcription factors. Cancer Res. 56:1996;5513-5521.
36. Lee J. C., Laydon J. T., McDonnell P. C., Gallagher T. F., Kumar S., Green D., McNulty D., Blumenthal M. J., Heys J. R., Landvatter S. W. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
37. Cuenda A., Rouse J., Doza Y. N., Meier R., Cohen P., Gallagher T. F., Young P. R., Lee J. C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
38. Frantz B., Klatt T., Pang M., Parsons J., Rolando A., Williams H., Tocci M. J., O'Keefe S. J., O'Neill E. A. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry. 37:1998;13846-13853.
39. 3. J. Immunol. 153:1994;3276-3284.
40. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 55:1971;283-290.
41. Griffin J. D., Ritz J., Nadler L. M., Schlossman S. F. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J. Clin. Invest. 68:1981;923-941.
42. rk MAP kinase cascades in HL-60 cells is PKC dependent but not essential for differentiation to the macrophage like phenotype. J. Cell Physiol. 173:1997;310-318.
43. Maher P. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J. Biol. Chem. 274:1999;17491-17498.
44. 3 in HL60 cells. Cancer Res. 56:1996;264-267.
45. Pulverer B. J., Kyriakis J. M., Avruch J., Nikolakaki E., Woodgett J. R. Phosphorylation of c-jun mediated by MAP kinases. Nature. 353:1991;670-674.
46. van Dam H., Duyndam M., Rottier R., Bosch A., deVries-Smits L., Herrlich P., Zantema A., Angel P., van der Eb A. J. Heterodimer formation of c-jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 2:1993;479-487.
47. Karin M., Hunter T. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus. Curr. Biol. 5:1995;747-757.
48. Carter-Lange C. A., Pleiman C. M., Gardner A. M., Blumer K. J., Johnson G. L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science. 260:1993;315-317.
49. Minden A, Lin A., McMahon M., Lange-Carter C., Derijard B., Davis R. J., Johnson G. L., Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by raf-1 and MEKK. Science. 266:1994;1719-1723.
50. Xu S., Robbins D., Frost J., Dang A., Carter-Lange C., Cobb M. H. MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA. 92:1995;6808-6812.
51. Borsch-Haubold A. G., Pasquet S., Watson S. P. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J. Biol. Chem. 273:1998;28766-28772.
52. 3 in HL-60 cells. J. Biol. Chem. 265:1990;2370-2374.
53. Cai H., Smola U., Wixler V., Eisenmann-Tappe I., Diaz-Meco M. T., Moscat J., Rapp U., Cooper G. M. Role of diacylglycerol-regulated protein kinase C isotype in growth factor activation of the Raf-1 protein kinase. Mol. Cell Biol. 17:1997;732-741.
54. Marais R., Wynne J., Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activated domain. Cell. 73:1993;381-393.
55. Treinies I., Paterson H. F., Hooper S., Wilson R., Marshall C. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell Biol. 19:1999;321-329.
56. Szabo E., Preis L. H., Brown P. H., Birrer M. J. The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation. Cell Growth Differ. 2:1991;475-482.
57. 3. J. Cell Physiol. 156:1993;63-71.
58. Kharbanda S., Saleem A., Emoto Y., Stone R., Rapp U., Kufe D. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J. Biol. Chem. 269:1994;872-878.
59. Yen A., Roberson M. S., Varvayanis S. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell Dev. Biol. Anim. 35:1999;527-532.